Somatic Symptom Disorder (DSM-5) F45.1
Conditions
Interventions
Group 1: intervention group – receives an HRV biofeedback training over 4 weeks including one session weekly
Group 2: control group – receives autogenic training over 4 weeks including one session wee
Sponsors
Bergische Universität Wuppertal
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: primary diagnosis somatic symptom disorder age between 18 and 65 years a minimum PHQ-15 score of 5
Exclusion criteria
Exclusion criteria: Pacemaker No stable medication Acute heart disease (e.g. myocarditis) Diabetes rheumatism
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Impairment due to the somatic symptoms (Screening für somatoforme Störungen (SOMS-7), numeric rating scale (NRS) for symptom intensity and symptom interference and HRV by ECG (bio-feedback-device Nexus-4) Assessment is carried out for the HRV and NRS every session, and for the SOMS-7 before and after the intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.SSD symptomatology by use of questionnaires: Somatic Symptom Disorder 12 (SSD-12) Pain Disability Questionnaire (PDI) Numeric rating scale for subjective controllability and health concerns (NRS-C, NRS-HC) 2.General psychopathology: Depressive symptoms by use of Patient Health Questionnaire (PHQ-9) and anxiety symptoms by use of Generalized Anxiety Disorder Scale (GAD-7) Emotionregulation strategies by use of the Heidelberger Fragebogen für Emotionsregulation (H-Ferst) Interoception by 2 subscales (noticing and attention regulation) of the Multidimen-sional Assessment of Interoceptive Awareness (MAIA) Internal control beliefs (KKG-I, specific for relaxation) 3.Credibility and expectancy by use of the Credibility and Expectancy questionnaire (CEQ) 4.Further instruments: general evaluation questionnaire | — |
Countries
Germany
Contacts
Public ContactLaura Klewinghaus
Bergische Universität Wuppertal Klinische Psychologie und Psychotherapie
Outcome results
None listed